These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20541059)

  • 1. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
    Ng A; Constine LS; Advani R; Das P; Flowers C; Friedberg J; Hodgson DC; Schwartz CL; Wilder RB; Wilson LD; Yunes MJ
    Curr Probl Cancer; 2010; 34(3):211-27. PubMed ID: 20541059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
    Deming RL; Constine LS; Elman AJ; Hoppe RT; Mauch PM; Dosoretz DE; Pistenmaa DA; Prosnitz LR; Wolkov HB; Yahalom J; Chauvenet A; Connors JM; Glick JH; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1269-79. PubMed ID: 11037546
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma.
    Perez EA; Loprinzi CL; Sloan JA; Owens DT; Novotny PJ; Bonner JA
    Cancer; 1997 Aug; 80(4):676-80. PubMed ID: 9264350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACR appropriateness criteria follow-up of Hodgkin lymphoma.
    Ha CS; Hodgson DC; Advani R; Dabaja BS; Dhakal S; Flowers CR; Hoppe BS; Mendenhall NP; Metzger ML; Plastaras JP; Roberts KB; Shapiro R; Smith S; Terezakis SA; Winkfield KM; Younes A; Constine LS
    J Am Coll Radiol; 2014 Nov; 11(11):1026-1033.e3. PubMed ID: 25278496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
    Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
    Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of treatment for Hodgkin's disease: the University Hospital Sofia experience.
    Gocheva L; Koleva I
    Klin Onkol; 2010; 23(1):34-42. PubMed ID: 20192072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
    Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
    J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.